Invention Grant
![N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity](/docs/US/2020-08-11/US10738031B2/abs.jpg.600x600.jpg)
- Patent Title: N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity
-
Application No.: US16090632Application Date: 2017-04-07
-
Publication No.: US10738031B2Publication Date: 2020-08-11
- Inventor: Doris Riether , Marco Ferrara , Niklas Heine , Uta Lessel , Janet Rachel Nicholson , Anton Pekcec
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Robert J. Kajubi
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4bbe1e41
- International Application: PCT/EP2017/058321 WO 20170407
- International Announcement: WO2017/178344 WO 20171019
- Main IPC: A61K31/16
- IPC: A61K31/16 ; C07C233/57 ; C07D401/14 ; C07D403/12 ; C07D413/14 ; C07D401/12 ; C07D239/34 ; C07D213/81
![N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity](/abs-image/US/2020/08/11/US10738031B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar1 and Ar2 have meanings given in the description.
Public/Granted literature
- US20190112292A1 NOVEL N-[(HETEROARYLOXY)PROPANYL]HETEROARYL CARBOXAMIDES Public/Granted day:2019-04-18
Information query
